 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
IQVIA Holdings Inc. (IQV) provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific.
It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.
The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services.
The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. The company serves pharmaceutical, biotechnology, device and diagnostic, and healthcare companies.
Shares are heading higher in an upward trading channel. The lower boundary of the said channel coincides with the stock's 50-day moving average. Higher share prices are expected for this stock.
Entry Point: $125.00
Stop Loss: $118.75
Trading Range: $91.57 - $135.48
Target Price: $137.50
IQV CLOSED AT $126.20
